Voloridge Investment Management LLC Has $41.69 Million Holdings in UiPath Inc. (NYSE:PATH)

Voloridge Investment Management LLC decreased its holdings in UiPath Inc. (NYSE:PATH) by 27.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,279,934 shares of the company’s stock after selling 1,233,062 shares during the period. Voloridge Investment Management LLC owned about 0.60% of UiPath worth $41,688,000 as of its most recent SEC filing.

A number of other large investors also recently made changes to their positions in PATH. Smartleaf Asset Management LLC grew its position in UiPath by 88.5% during the fourth quarter. Smartleaf Asset Management LLC now owns 2,454 shares of the company’s stock valued at $31,000 after purchasing an additional 1,152 shares in the last quarter. First Horizon Advisors Inc. boosted its stake in shares of UiPath by 47.8% during the 4th quarter. First Horizon Advisors Inc. now owns 2,487 shares of the company’s stock valued at $32,000 after buying an additional 804 shares during the period. EverSource Wealth Advisors LLC grew its holdings in shares of UiPath by 141.4% during the 4th quarter. EverSource Wealth Advisors LLC now owns 2,974 shares of the company’s stock valued at $38,000 after acquiring an additional 1,742 shares in the last quarter. V Square Quantitative Management LLC increased its stake in shares of UiPath by 33.4% in the fourth quarter. V Square Quantitative Management LLC now owns 3,030 shares of the company’s stock worth $39,000 after acquiring an additional 759 shares during the last quarter. Finally, Harvest Fund Management Co. Ltd acquired a new position in shares of UiPath in the fourth quarter worth $50,000. Institutional investors and hedge funds own 62.50% of the company’s stock.

UiPath Price Performance

UiPath stock opened at $12.44 on Wednesday. UiPath Inc. has a fifty-two week low of $9.38 and a fifty-two week high of $20.36. The firm has a fifty day moving average price of $11.25 and a two-hundred day moving average price of $12.72. The firm has a market cap of $6.86 billion, a price-to-earnings ratio of -77.75 and a beta of 1.01.

Insider Transactions at UiPath

In other news, CFO Ashim Gupta sold 98,795 shares of the firm’s stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $12.01, for a total value of $1,186,527.95. Following the sale, the chief financial officer now owns 987,322 shares in the company, valued at approximately $11,857,737.22. This trade represents a 9.10% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CAO Hitesh Ramani sold 12,500 shares of the company’s stock in a transaction on Thursday, April 3rd. The shares were sold at an average price of $10.19, for a total transaction of $127,375.00. Following the transaction, the chief accounting officer now owns 314,891 shares of the company’s stock, valued at approximately $3,208,739.29. The trade was a 3.82% decrease in their ownership of the stock. The disclosure for this sale can be found here. 23.19% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on PATH. Scotiabank reduced their price objective on UiPath from $15.00 to $12.00 and set a “sector perform” rating for the company in a research report on Thursday, March 13th. Morgan Stanley reduced their price target on UiPath from $16.00 to $12.00 and set an “equal weight” rating for the company in a report on Thursday, March 13th. Evercore ISI dropped their price objective on UiPath from $16.00 to $12.00 and set an “in-line” rating on the stock in a report on Thursday, March 13th. UBS Group cut their price objective on shares of UiPath from $14.00 to $10.00 and set a “sell” rating on the stock in a research report on Thursday, March 13th. Finally, BMO Capital Markets decreased their target price on shares of UiPath from $16.00 to $11.50 and set a “market perform” rating for the company in a research report on Friday, March 14th. Two research analysts have rated the stock with a sell rating, fifteen have issued a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat.com, UiPath has a consensus rating of “Hold” and a consensus target price of $12.72.

UiPath Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.